Again, a great question for your doctor!! Discuss this with them. One very good option is always simply not to do it. You are the best one to weigh the pros and cons that your doctor lays out for you and decide what is the right decision for you. One thing that people often fail to realize is that the normal range for testosterone is that – a NORMAL RANGE. That means that readings anywhere in that range are NORMAL. If you are on the “low side of normal” – that is NORMAL. Another thing to realize is that doctors to not treat test results, they treat symptoms. Just because your testosterone comes in at 200 does not necessarily mean you need TRT! See also the below question.
The original brand name of oxandrolone was Anavar, which was marketed in the United States and the Netherlands .   This product was eventually discontinued and replaced in the United States with a new product named Oxandrin, which is the sole remaining brand name for oxandrolone in the United States.   Oxandrolone has also been sold under the brand names Antitriol ( Spain ), Anatrophill ( France ), Lipidex ( Brazil ), Lonavar ( Argentina , Australia , Italy ), Protivar, and Vasorome ( Japan ) among others.     Additional brand names exist for products that are manufactured for the steroid black market. 
Hemosuccus pancreaticus , also known as pseudohematobilia or Wirsungorrhage , is a rare cause of hemorrhage in the gastrointestinal tract . It is caused by a bleeding source in the pancreas, pancreatic duct, or structures adjacent to the pancreas, such as the splenic artery , that bleed into the pancreatic duct. Patients with hemosuccus may develop symptoms of gastrointestinal hemorrhage, such as blood in the stools, maroon stools, or melena . They may also develop abdominal pain. Hemosuccus pancreaticus is associated with pancreatitis , pancreatic cancer and aneurysms of the splenic artery . Angiography may be used to diagnose hemosuccus pancreaticus, where the celiac axis is injected to determine the blood vessel that is bleeding. Concomitant embolization of the end vessel may terminate the hemorrhage. Alternatively, a distal pancreatectomy may be required to stop the hemorrhage.